This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
DSM Aktienübersicht
Provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 6/6 |
| Künftiges Wachstum | 4/6 |
| Vergangene Leistung | 1/6 |
| Finanzielle Gesundheit | 6/6 |
| Dividenden | 3/6 |
Belohnungen
Risikoanalyse
DSM-Firmenich AG Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | €114.05 |
| 52-Wochen-Hoch | €160.10 |
| 52-Wochen-Tief | €105.80 |
| Beta | 0.72 |
| 11 Monat Veränderung | -3.96% |
| 3 Monate Veränderung | -4.32% |
| 1 Jahr Veränderung | -26.49% |
| 33 Jahre Veränderung | -3.96% |
| 5 Jahre Veränderung | 28.70% |
| Veränderung seit IPO | 1,649.00% |
Aktuelle Nachrichten und Updates
Recent updates
Analyst Forecasts For Koninklijke DSM N.V. (AMS:DSM) Are Surging Higher
May 04
Koninklijke DSM (AMS:DSM) Is Reinvesting At Lower Rates Of Return
Mar 27Is Koninklijke DSM (AMS:DSM) A Risky Investment?
Mar 09Here's Why We Think Koninklijke DSM (AMS:DSM) Is Well Worth Watching
Dec 06Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Nov 18Estimating The Fair Value Of Koninklijke DSM N.V. (AMS:DSM)
Oct 31Why Koninklijke DSM N.V. (AMS:DSM) Could Be Worth Watching
Sep 19Is Now The Time To Put Koninklijke DSM (AMS:DSM) On Your Watchlist?
Aug 23Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Aug 08Calculating The Intrinsic Value Of Koninklijke DSM N.V. (AMS:DSM)
Jul 23Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70
Apr 30Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70
Apr 16Koninklijke DSM's (AMS:DSM) Upcoming Dividend Will Be Larger Than Last Year's
Apr 02Koninklijke DSM's (AMS:DSM) Dividend Will Be Increased To €1.70
Mar 19Koninklijke DSM (AMS:DSM) Seems To Use Debt Rather Sparingly
Feb 19Are Koninklijke DSM N.V. (AMS:DSM) Investors Paying Above The Intrinsic Value?
Nov 23We Think Koninklijke DSM (AMS:DSM) Can Stay On Top Of Its Debt
Oct 01Does This Valuation Of Koninklijke DSM N.V. (AMS:DSM) Imply Investors Are Overpaying?
Aug 24Koninklijke DSM (AMS:DSM) Has A Pretty Healthy Balance Sheet
Jun 29Koninklijke DSM N.V.'s (AMS:DSM) Intrinsic Value Is Potentially 17% Below Its Share Price
May 24Is Koninklijke DSM (AMS:DSM) A Risky Investment?
Mar 29Should Koninklijke DSM N.V. (AMS:DSM) Be Part Of Your Dividend Portfolio?
Mar 15Are Koninklijke DSM N.V.'s (AMS:DSM) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 01Koninklijke DSM (AMS:DSM) Has Gifted Shareholders With A Fantastic 276% Total Return On Their Investment
Feb 16Need To Know: Koninklijke DSM N.V. (AMS:DSM) Insiders Have Been Selling Shares
Feb 04
Aktionärsrenditen
| DSM | NL Chemicals | NL Markt | |
|---|---|---|---|
| 7D | 0.3% | -2.5% | -0.8% |
| 1Y | -26.5% | 21.0% | 19.9% |
Rendite im Vergleich zur Industrie: DSM underperformed the Dutch Chemicals industry which returned -20.7% over the past year.
Rendite vs. Markt: DSM underperformed the Dutch Market which returned 9.1% over the past year.
Preisvolatilität
| DSM volatility | |
|---|---|
| DSM Average Weekly Movement | 3.2% |
| Chemicals Industry Average Movement | 3.8% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in NL Market | 7.5% |
| 10% least volatile stocks in NL Market | 2.4% |
Stabiler Aktienkurs: DSM has not had significant price volatility in the past 3 months.
Volatilität im Zeitverlauf: DSM's weekly volatility (3%) has been stable over the past year.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1902 | 19,973 | Dimitri de Vreeze | www.dsm-firmenich.com |
DSM-Firmenich AG's Grundlagenzusammenfassung
| DSM grundlegende Statistiken | |
|---|---|
| Marktanteil | €763.73m |
| Gewinn(TTM) | €454.00m |
| Umsatz(TTM) | €8.39b |
1.7x
Kurs-Gewinn-Verhältnis0.1x
Kurs-Umsatz-VerhältnisIst DSM zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| DSM Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | €8.39b |
| Kosten der Einnahmen | €5.70b |
| Bruttogewinn | €2.69b |
| Sonstige Ausgaben | €2.24b |
| Umsatz | €454.00m |
Zuletzt gemeldete Gewinne
Dec 31, 2022
Datum des nächsten Gewinnberichts
Aug 02, 2023
| Gewinn per Aktie (EPS) | 67.80 |
| Bruttomarge | 32.06% |
| Nettogewinnspanne | 5.41% |
| Schulden/Eigenkapital-Verhältnis | 26.6% |
Wie hat sich DSM auf lange Sicht entwickelt?
Historische Performance und Vergleiche